OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
40
Results
Show all
Save search
Copy query
Show results for
Unknown
(40)
Release Date
2021
(11)
2022
(6)
2023
(5)
2025
(4)
2018
(3)
2024
(2)
2017
(2)
2015
(2)
2026
(1)
2020
(1)
2019
(1)
2016
(1)
2009
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Not available
S-EPMC10357473
|
biostudies-literature
Cite
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.
Not available
S-EPMC5761650
|
biostudies-literature
Cite
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Not available
S-EPMC8148035
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
Not available
S-EPMC10424812
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Not available
S-EPMC10841479
|
biostudies-literature
Cite
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Not available
S-EPMC2846760
|
biostudies-literature
Cite
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.
Not available
S-EPMC4572072
|
biostudies-literature
Cite
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets